Best TWAS P=6.2e-30 · Best GWAS P=2.34e-21 conditioned to 0.00206
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Artery Tibial | CACFD1 | 0.10 | 0.03 | lasso | 4 | 0.03 | 1.7e-03 | -1.5 | 5.5 | 3.9e-08 | 0.41 | 0.13 | 0.37 | FALSE |
2 | GTEx | Testis | CACFD1 | 0.26 | 0.05 | enet | 25 | 0.10 | 5.3e-05 | 6.7 | 5.5 | 3.1e-08 | 0.34 | 0.30 | 0.15 | FALSE |
3 | The Cancer Genome Atlas | Breast Invasive Carcinoma | ABO | 0.07 | 0.08 | lasso | 3 | 0.08 | 5.0e-16 | 7.3 | 7.1 | 1.0e-12 | 0.63 | 1.00 | 0.00 | FALSE |
4 | The Cancer Genome Atlas | Breast Invasive Carcinoma | OBP2B | 0.03 | 0.02 | blup | 33 | 0.02 | 5.5e-05 | -5.2 | 6.6 | 3.3e-11 | 0.21 | 0.23 | 0.46 | FALSE |
5 | The Cancer Genome Atlas | Colon Adenocarcinoma | ABO | 0.27 | 0.31 | blup | 43 | 0.33 | 2.1e-19 | 6.9 | 5.1 | 2.7e-07 | 0.52 | 1.00 | 0.00 | FALSE |
6 | The Cancer Genome Atlas | Esophageal Carcinoma | ABO | 0.27 | 0.13 | lasso | 2 | 0.11 | 1.8e-04 | 6.9 | 6.9 | 5.3e-12 | 0.63 | 0.35 | 0.03 | FALSE |
7 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | ABO | 0.20 | 0.19 | blup | 43 | 0.33 | 3.0e-38 | -3.8 | 5.6 | 1.7e-08 | 0.37 | 1.00 | 0.00 | FALSE |
8 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | ABO | 0.31 | 0.38 | lasso | 5 | 0.42 | 3.1e-26 | 8.1 | 7.7 | 1.4e-14 | 0.54 | 1.00 | 0.00 | FALSE |
9 | The Cancer Genome Atlas | Brain Lower Grade Glioma | ABO | 0.26 | 0.23 | enet | 10 | 0.26 | 6.0e-29 | 7.3 | 6.4 | 1.2e-10 | 0.66 | 1.00 | 0.00 | FALSE |
10 | The Cancer Genome Atlas | Liver Hepatocellular Carcinoma | ABO | 0.23 | 0.23 | lasso | 2 | 0.24 | 2.2e-11 | 8.1 | 8.1 | 8.2e-16 | 0.53 | 1.00 | 0.00 | FALSE |
11 | The Cancer Genome Atlas | Lung Adenocarcinoma | ABO | 0.21 | 0.25 | lasso | 5 | 0.25 | 2.1e-29 | 7.3 | 7.2 | 5.6e-13 | 0.59 | 1.00 | 0.00 | FALSE |
12 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | ABO | 0.08 | 0.06 | blup | 43 | 0.09 | 1.7e-10 | 7.3 | 5.8 | 7.1e-09 | 0.40 | 1.00 | 0.00 | FALSE |
13 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | ABO | 0.28 | 0.22 | lasso | 8 | 0.22 | 1.2e-14 | 7.3 | 7.5 | 6.9e-14 | 0.63 | 1.00 | 0.00 | FALSE |
14 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | ABO | 0.23 | 0.21 | lasso | 5 | 0.20 | 6.7e-09 | 8.1 | 6.0 | 2.1e-09 | 0.49 | 0.99 | 0.00 | FALSE |
15 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | ABO | 0.23 | 0.23 | lasso | 3 | 0.23 | 2.0e-09 | 6.9 | 7.2 | 5.5e-13 | 0.61 | 0.99 | 0.00 | FALSE |
16 | The Cancer Genome Atlas | Rectum Adenocarcinoma | ABO | 0.48 | 0.23 | enet | 10 | 0.27 | 4.7e-07 | 8.3 | 8.2 | 3.0e-16 | 0.65 | 0.18 | 0.24 | FALSE |
17 | The Cancer Genome Atlas | Soft Tissue Sarcoma | ABO | 0.32 | 0.18 | enet | 10 | 0.20 | 2.3e-12 | 7.3 | 5.2 | 1.9e-07 | 0.49 | 1.00 | 0.00 | FALSE |
18 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | ABO | 0.41 | 0.17 | enet | 12 | 0.25 | 3.0e-09 | -3.9 | 5.9 | 3.6e-09 | 0.37 | 0.85 | 0.02 | FALSE |
19 | The Cancer Genome Atlas | Thyroid Carcinoma | ABO | 0.44 | 0.57 | enet | 18 | 0.60 | 1.9e-73 | 7.3 | 6.5 | 8.4e-11 | 0.51 | 1.00 | 0.00 | FALSE |
20 | The Cancer Genome Atlas | Uterine Corpus Endometrial Carcinoma | ABO | 0.23 | 0.07 | blup | 44 | 0.12 | 4.3e-04 | 8.1 | 11.4 | 6.2e-30 | 0.62 | 0.02 | 0.15 | TRUE |